COMPANY

Precision Biologics

HQ: Bethesda, MD source · precision-biologics.com ↗

Keywords: oncology Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma Cervical Cancer Uterine Cancer Adult Pancreatic Cancer Metastatic Pancreatic Cancer Metastatic Colorectal Cancer NPC-1C/NEO-102

Location: Bethesda, MD · source · Oct 15, 2026

Profile checked Oct 10, 2026

3Trials (company is sponsor)

Timeline

Jan 18, 2019 Trial start Phase 1/Phase 2: Study of NEO-201 in Solid Tumors Expansion Cohorts source ↗
2013-04 Trial start Phase 1/Phase 2: QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer source ↗
2012-01 Trial start 2: QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer source ↗

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT03476681	Study of NEO-201 in Solid Tumors Expansion Cohorts	Phase 1/Phase 2	Active, not recruiting	Jan 18, 2019	Jun 17, 2026 (actual)
NCT01834235	QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer	Phase 1/Phase 2	Terminated	2013-04	Mar 13, 2017 (actual)
NCT01040000	QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer	2	Completed	2012-01	2017-03 (actual)